Evidence map›Paper›PMID 37027294›Full record

ArticleCell reports2023

Neurons require glucose uptake and glycolysis in vivo.

Huihui Li, Caroline Guglielmetti, Yoshitaka J Sei, Misha Zilberter, Lydia M Le Page, Lauren Shields, Joyce Yang, Kevin Nguyen, Brice Tiret, Xiao Gao and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 2 pooled it
18.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 2 syntheses or guidelines pooled it, 119 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Neurons run on fat.npj metabolic health and disease · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. HyperpolarizedResearch square · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Learning Shapes the Energy Cost of Neural Tasks.bioRxiv : the preprint server for biology · 2026
    Article
  17. Article
  18. Article
  19. Review
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Huihui LiGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.
Caroline GuglielmettiDepartment of Physical Therapy and Rehabilitation Science, San Francisco, CA 94158, USA; Department of Radiology and Biomedical Imaging, San Francisco, CA 94158, USA.
Yoshitaka J SeiGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.
Misha ZilberterGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.
Lydia M Le PageDepartment of Physical Therapy and Rehabilitation Science, San Francisco, CA 94158, USA; Department of Radiology and Biomedical Imaging, San Francisco, CA 94158, USA.
Lauren ShieldsGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA; Graduate Program in Biomedical Sciences, University of California San Francisco, San Francisco, CA 94143, USA.
Joyce YangGraduate Program in Neuroscience, University of California San Francisco, San Francisco, CA 94158, USA.
Kevin NguyenGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.
Brice TiretDepartment of Physical Therapy and Rehabilitation Science, San Francisco, CA 94158, USA; Department of Radiology and Biomedical Imaging, San Francisco, CA 94158, USA.
Xiao GaoDepartment of Physical Therapy and Rehabilitation Science, San Francisco, CA 94158, USA; Department of Radiology and Biomedical Imaging, San Francisco, CA 94158, USA; UCSF/UCB Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA 94158, USA.
Neal BennettGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.
Iris LoGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA.
Talya L DaytonKoch Institute for Integrative Cancer Research and the Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Martin KampmannGraduate Program in Biomedical Sciences, University of California San Francisco, San Francisco, CA 94143, USA; Graduate Program in Neuroscience, University of California San Francisco, San Francisco, CA 94158, USA; UCSF/UCB Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA 94158, USA; Institute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, CA, USA; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.
Yadong HuangGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA; Graduate Program in Biomedical Sciences, University of California San Francisco, San Francisco, CA 94143, USA; Graduate Program in Neuroscience, University of California San Francisco, San Francisco, CA 94158, USA; Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA.
Jeffrey C RathmellVanderbilt Center for Immunobiology, Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Matthew Vander HeidenKoch Institute for Integrative Cancer Research and the Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Myriam M ChaumeilDepartment of Physical Therapy and Rehabilitation Science, San Francisco, CA 94158, USA; Department of Radiology and Biomedical Imaging, San Francisco, CA 94158, USA; Graduate Program in Biomedical Sciences, University of California San Francisco, San Francisco, CA 94143, USA; UCSF/UCB Graduate Program in Bioengineering, University of California San Francisco, San Francisco, CA 94158, USA. Electronic address: myriam.chaumeil@ucsf.edu.
Ken NakamuraGladstone Institute of Neurological Disease, Gladstone Institutes, San Francisco, CA 94158, USA; Graduate Program in Biomedical Sciences, University of California San Francisco, San Francisco, CA 94143, USA; Graduate Program in Neuroscience, University of California San Francisco, San Francisco, CA 94158, USA; Department of Neurology, University of California, San Francisco, San Francisco, CA 94158, USA. Electronic address: ken.nakamura@gladstone.ucsf.edu.
Gladstone Institutes · USUniversity of California, San Francisco · USDana-Farber Cancer Institute · USMassachusetts Institute of Technology · USVanderbilt University Medical Center · US

Funding

Project 4: Cross-species Dissection of Cellular Response to APOE Genotype and AD Pathology Using Single-cell Multi-omicsP01AG073082 · NIA · J. DAVID GLADSTONE INSTITUTES · PI CORCES, MICHAEL RYAN · 2021 to 2025
$23.4M
Understanding the role of metabolism in cancerR35CA242379 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI VANDER HEIDEN, MATTHEW G. · 2019 to 2025
$5.8M
Exploiting metabolic vulnerabilities of CD4 T cell subsets to control inflammatory diseaseR01DK105550 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey C Rathmell · 2015 to 2026
$4.7M
Neuronal ApoE Drives Selective Neurodegeneration in Alzheimer's DiseaseR01AG071697 · NIA · J. DAVID GLADSTONE INSTITUTES · PI HUANG, YADONG · 2021 to 2025
$4.1M
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human CellsR01AG065428 · NIA · J. DAVID GLADSTONE INSTITUTES · PI NAKAMURA, KEN · 2020 to 2024
$3.7M
Understand and probing disrupted glucose metabolism in Alzheimer's diseaseRF1AG064170 · NIA · J. DAVID GLADSTONE INSTITUTES · PI CHAUMEIL, MYRIAM MARIANNE, NAKAMURA, KEN · 2019 to 2019
$3.6M
MR Metabolic Imaging of Multiple SclerosisR01NS102156 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jeremy William Gordon, Ari J Green · 2017 to 2026
$3.4M
Apolipoprotein E4-related Electrophysiological and Metabolic Impairments in Aging and Alzheimer's DiseaseR01AG061150 · NIA · J. DAVID GLADSTONE INSTITUTES · PI ZILBERTER, MISHA YURI · 2019 to 2023
$3.3M
EXTRAMULAR RESEARCH FACILITIES CONSTRUCTIONC06RR018928 · NCRR · J. DAVID GLADSTONE INSTITUTES · PI MAHLEY, ROBERT W. · 2003 to 2003
$2.1M
Regulation of glucose metabolism to allow tumor initiation and growthR01CA168653 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI VANDER HEIDEN, MATTHEW G. · 2013 to 2019
$1.9M
Metabolic Vulnerability and Effects of APOE in Human Neurons with Impaired Endocytic RecyclingK01AG078485 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI Neal Bennett · 2022 to 2026
$643k
Imaging innate and adaptive immune response in MS using using [18F]F-AraG PET and hyperpolarized 13C MRSIR21AI153749 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHAUMEIL, MYRIAM MARIANNE, GUGLIELMETTI, CAROLINE · 2020 to 2021
$444k
NCI NIH HHS R01 CA168653NCI NIH HHS R35 CA242379NCRR NIH HHS C06 RR018928NIAID NIH HHS R21 AI153749NIA NIH HHS K01 AG078485NIA NIH HHS P01 AG073082NIA NIH HHS R01 AG061150NIA NIH HHS R01 AG065428NIA NIH HHS R01 AG071697NIA NIH HHS RF1 AG064170NIDDK NIH HHS R01 DK105550NINDS NIH HHS R01 NS102156
6 · The paper itself

Abstract

Neurons require large amounts of energy, but whether they can perform glycolysis or require glycolysis to maintain energy remains unclear. Using metabolomics, we show that human neurons do metabolize glucose through glycolysis and can rely on glycolysis to supply tricarboxylic acid (TCA) cycle metabolites. To investigate the requirement for glycolysis, we generated mice with postnatal deletion of either the dominant neuronal glucose transporter (GLUT3cKO) or the neuronal-enriched pyruvate kinase isoform (PKM1cKO) in CA1 and other hippocampal neurons. GLUT3cKO and PKM1cKO mice show age-dependent learning and memory deficits. Hyperpolarized magnetic resonance spectroscopic (MRS) imaging shows that female PKM1cKO mice have increased pyruvate-to-lactate conversion, whereas female GLUT3cKO mice have decreased conversion, body weight, and brain volume. GLUT3KO neurons also have decreased cytosolic glucose and ATP at nerve terminals, with spatial genomics and metabolomics revealing compensatory changes in mitochondrial bioenergetics and galactose metabolism. Therefore, neurons metabolize glucose through glycolysis in vivo and require glycolysis for normal function.

Indexed as

Energy MetabolismGlycolysisAnimalsFemaleGlucoseHumansMagnetic Resonance ImagingMiceNeuronsGlucosebioenergeticsbrain energyCP: Neurosciencegalactose metabolismglucose transporterglycolysishyperpolarized magnetic resonance spectroscopic imagingmetabolomicsneuronal glucose metabolismpyruvate kinase

Identifiers

PMID37027294
PMCPMC10556202
OpenAlexW4362662630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.